Inositol Listings: Separate a Myo-Form Description from a Two-Form Ratio
Compare exact form names and declared components before treating a myo-inositol capsule and a myo/D-chiro blend as the same formula.
We have not performed hands-on testing of the products discussed. Manufacturer references and official guidance support the documented information below; comparison exercises are our editorial guidance.
Inositol can appear as a short ingredient name, a more specific form description or a ratio between two named forms. Those expressions do different jobs in a product record. The two manufacturer examples here make the distinctions visible. This reading exercise does not select a ratio, identify a personal need or endorse claims associated with either product.
Find where the specific form is documented
NOW’s consulted 500 mg capsule panel uses the name inositol, while the product description identifies its form as myo-inositol. Keep both pieces with their source locations rather than silently rewriting the panel. That distinction tells a reviewer whether the specificity came from the printed entry, the manufacturer’s explanatory text or an unsupported assumption based on a similar-looking product.
Read a two-form ratio as a relationship
Theralogix’s Ovasitol page identifies myo-inositol and D-chiro-inositol and describes a 40:1 relationship. It is a two-form product description, not another name for every inositol supplement. A ratio alone cannot identify a whole formula without the form names and their declared amounts. Do not reconstruct missing component statements from a headline or use the relationship to make a custom mixture.
Worked example: change the comparison headings
Suppose an illustrative table has one column labelled inositol and places the capsule and powder blend in it as identical options. Replace that single column with panel wording, additional maker form description and separately named components. The capsule has one declared ingredient entry with a myo-form description. The powder has two named forms and a stated relationship. The new table answers the identity question without converting one product into the other or calculating how someone might consume either.
Preserve the exact named variant
The Ovasitol page distinguishes the original product from a Plus version that includes additional ingredients. Keep that variant name in a separate product row even when the same inositol ratio appears in both descriptions. A shared relationship between two components does not prove an otherwise identical formula. When comparing canisters, packets and capsules, obtain the full current label for each; the shopping format cannot fill a missing isomer description. FDA’s general consumer resource provides the US category framework but does not approve a particular ratio or purpose claim. The useful endpoint is a record that explains exactly where each identity statement came from. Discuss personal use questions with a qualified health professional and leave unclear offers unresolved.
Compare the trade-offs
| Option | Useful when | Purchase limitation |
|---|---|---|
| Short panel name | Record inositol as printed | Do not erase the source location of greater specificity |
| Two-form blend | Names and explicit relationship | A ratio is not a universal ingredient identity |
| Plus variant | Additional full-formula rows | The same ratio does not mean the same product |
Your purchase checklist
- Distinguish panel wording from explanatory form text.
- Retain both names in a two-form relationship.
- Give original and Plus formulas separate records.
Sources and further reading
- NOW: Inositol 500 mg panel and myo-form description
- Theralogix: Ovasitol named forms, ratio and variant distinctions
- FDA: questions and answers on dietary supplements
Reference links concern the stated topic or example. They do not indicate endorsement of this publication. Product versions, local labels, availability and seller terms can change; verify the exact listing before ordering.